Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid for surgical bleeding in percutaneous nephrolithotomy
IRCT20180209038673N1Phase 3Completed
- Sponsor
- Vice Chancellor for Research of Isfahan University of Medical Sciences
- Start
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in staghorn calculus comparing Tranexamic acid with Placebo (2 arms). Primary endpoints: Bleeding and Hemoglobin. Started Jan 2017; status: completed.
02
Drugs
tranexamic acid
03
Conditions
staghorn calculus
Beyond the preview
Go deeper on IRCT20180209038673N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180209038673N1.